Table 3 Outcomes during ICU stay
‘Before group’ (n = 147) | ‘After group’ (n = 128) | Intensity rate ratio [CI 95%] | p | |||
|---|---|---|---|---|---|---|
Intensity rate | Intensity rate | |||||
Support | ||||||
Days with IMV | 3.99 (7.45) | 35.2% [28.6–43.3%] | 4.83 (8.89) | 33.7% [27.0–42.1%] | 0.96 [0.71–1.30] | 0.79 |
Days with vasopressors | 2.76 (4.16) | 24.3% [18.9–31.3%] | 2.56 (3.35) | 17.9% [14.5–22.1%] | 0.74 [0.53–1.02] | 0.07 |
Days with dialysis | 1.06 (2.67) | 9.4% [6.2–14.2%] | 2.06 (4.72) | 14.4% [10.3–20.2%] | 1.54 [0.90–2.63] | 0.12 |
Days with antibiotics | 8.90 (7.85) | 78.3% [69.4–88.3%] | 12.38 (11.34) | 86.4% [81.9–91.2%] | 1.10 [0.97–1.26] | 0.14 |
Number of antibiotics used during ICU stay | 3.07 (1.86) | 3.52 (2.03) | 0.91 [0.73–1.12] | 0.37 | ||
Infections | ||||||
ICU-acquired infection | 34 (23.13) | 40 (31.25) | 0.13 | |||
VAP | 18 (12.24) | 16 (12.50) | 0.95 | |||
Bacteremia | 12 (8.16) | 18 (14.06) | 0.12 | |||
CVC-related infection | 4 (2.72) | 4 (3.13) | 1 | |||
Urinary tract infection | 5 (3.40) | 8 (6.25) | 0.27 | |||